Rosa is originally from Monterrey, Mexico where she completed her Bachelor's degree in Genomic Biotechnology from Universidad Autonoma de Nuevo Leon. She briefly worked at the Institute of Biotechnology from the same university before being awarded the Fulbright-Garcia Robles scholarship. She earned her PhD in Systems, Synthetic, and Physical Biology with her dissertation on novel CRISPR/Cas9-based epigenome editing tools for therapeutic applications in T cells. Dr. Guerra Resendez was awarded the NIH-NHLBI Martha Vaughan Postdoctoral Fellowship to continue her research at the National Heart, Lung, and Blood Institute, where she obtained the Fellows Award for Research Excellence.